Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1/2 Study of Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis

Next Previous
X
Search
Trial Profile

A Phase 1/2 Study of Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis

Status: Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 11 Jul 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs PRGN-2012 (Primary)
  • Indications Recurrent respiratory papillomatosis
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors PGEN Therapeutics; Precigen Inc

    • Most Recent Events

    • 04 Jun 2024 Results evaluating the safety and efficacy of PRGN-2012 in patients with RRP requiring a minimum of 3 surgeries in the 12 months prior to treatment were presented at the 60th Annual Meeting of the American Society of Clinical Oncology.
    • 03 Jun 2024 According to a Precigen Inc media release, Results were presented in a late-breaking oral presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting by Scott M. Norberg, DO, Associate Research Physician, Center for Immuno-Oncology, National Cancer Institute, who is a lead investigator for the PRGN-2012 clinical study.
    • 03 Jun 2024 According to the results published in the Precigen Inc Media Release, Primary endpoint (Determine the percentage of subjects with a complete response following treatment with PRGN-2012) has been met.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top